id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0257-0003,FDA,FDA-2007-D-0257,Draft Prescription Drug User Fee Act IV Information Technology Plan; Availability for Comment,Notice,N-Notice,2008-05-21T04:00:00Z,2008,5,2008-05-21T04:00:00Z,2008-02-23T04:59:59Z,2008-05-21T16:55:23Z,E7–25310,0,0,09000064805f6fac
FDA-2007-D-0257-0004,FDA,FDA-2007-D-0257,Draft Prescription Drug User Fee Act IV Information Technology Plan; Guidance Document,Other,GDL-Guidance (Supporting and Related Materials),2008-05-21T04:00:00Z,2008,5,2008-05-21T04:00:00Z,,2008-05-21T16:55:24Z,,0,0,09000064805f6fed
FDA-2007-D-0257-0001,FDA,FDA-2007-D-0257,See Document ID FDA-2007-D-0257-0003,Notice,,2007-12-28T00:00:00Z,2007,12,,,2008-05-21T20:22:03Z,,0,1,090000648042b1c1
FDA-2007-D-0257-0002,FDA,FDA-2007-D-0257,See Document ID FDA-2007-D-0257-0004,Other,,2007-12-28T00:00:00Z,2007,12,,,2008-05-21T20:21:19Z,,0,1,090000648042b1c4